SCHEMBL4613052

SCHEMBL4613052

O=C(NCS(=O)(=O)c1ccccc1)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.54
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
USP2 O75604 1/20 0.53
RAB9A P51151 2/20 0.52
EPHX2 P34913 2/20 0.52
NPC1 O15118 1/20 0.52
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
POLB P06746 1/20 0.51
ENPP3 O14638 3/20 0.50
ENPP1 P22413 3/20 0.50
ENPP2 Q13822 2/20 0.50
GAA P10253 1/20 0.49
ALOX12 P18054 1/20 0.48
JAK2 O60674 1/20 0.47
JAK1 P23458 1/20 0.47
TYK2 P29597 1/20 0.47
JAK3 P52333 1/20 0.47
MTNR1A P48039 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098178 0.77 KMT2A (0.60) MAPTALDH1A1HPGDUSP2RAB9A
SCHEMBL10538260 0.76 POLB (0.54) ALDH1A1HPGDRAB9ASMN1; SMN2POLB
SCHEMBL15791835 0.75 MAPT (0.70) MAPTALDH1A1
SCHEMBL11306682 0.75 MAPT (0.70) MAPTALDH1A1
SCHEMBL507837 0.74 ALDH1A1 (0.90) ALDH1A1HPGDUSP2RAB9ANPC1
SCHEMBL7927400 0.73 MAPT (0.68) MAPTALDH1A1SMN1; SMN2POLBMTNR1A
SCHEMBL6244724 0.72 ALDH1A1 (0.93) ALDH1A1HPGDUSP2RAB9ANPC1
Bicarbonate SCHEMBL15225927 0.72 RAB9A (0.54) MAPTALDH1A1RAB9AEPHX2NPC1
SCHEMBL23023336 0.72 SMN1; SMN2 (0.74) ALDH1A1HPGDUSP2RAB9AEPHX2
SCHEMBL3392745 0.72 ALDH1A1 (0.74) ALDH1A1HPGDUSP2RAB9AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1446115-B1 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA LTD (CA) 2008-02-27 EP disclosed
EP-1446115-A4 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA INC (CA) 2005-02-02 EP disclosed
EP-1446115-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS Merck Frosst Canada & Co. (CA) 2004-08-18 EP disclosed
WO-2003041649-A2 CYANOALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS MERCK FROSST CANADA & CO. (CA) 2003-05-22 WO disclosed